Sfoglia per AUTORE
D'ONOFRIO L
Collezione ASL Asti

  

Items : 3

Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study. in The journal of headache and pain / J Headache Pain. 2023 Mar 23;24(1):30. doi: 10.1186/s10194-023-01561-w.

2023
ASL Asti

Barbanti P; Egeo G; Aurilia C; Torelli P; Finocchi C; d'Onofrio F; d'Onofrio L; Rao R; Messina S; Di Clemente L; Ranieri A; Autunno M; Sette G; Colombo B; Carnevale A; Aguggia M; Tasillo M; Zoroddu F; Frediani F; Filippi M; Tomino C; Proietti S; Bonassi S;

Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study in European Journal of Neurology

2023
ASL Asti

Vernieri F; Brunelli N; Marcosano M; Aurilia C; Egeo G; Lovati C; Favoni V; Perrotta A; Maestrini I; Rao R; d'Onofrio L; Finocchi C; Aguggia M; Bono F; Ranieri A; Albanese M; Di Piero V; Cevoli S; Altamura C; Barbanti P; Costa CM; Fofi L; Di Cola FS; d’Onofrio F; Bertuzzo D; Bombardieri F; Messina R; Colombo B; Filippi M; et alii...

From the CLEOPATRA study to real life: Final results from the G.O.N.O. SUPER trial in Annals of Oncology

2020
ASL Asti

Garrone O; Giarratano T; Michelotti A; Saggia C; D'Onofrio L; Merlini L; Blondeaux E; Beano A; Coltelli L; Cazzaniga ME; Montemurro F; Farnesi A; La Verde NM; Vandone AM; Collovà E; Blasi L; Ardito R; DeConciliis E; Airoldi M; Merlano MC;